ANDAORALCAPSULE
Lifecycle
Pre-Launch
Clinical Trials
20
Clinical Trials (5)
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
Started Sep 2020
214 enrolled
Acute Myeloid Leukemia
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy
Started Dec 2019
777 enrolled
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Started Dec 2019
181 enrolled
Acute Myeloid Leukemia
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Started Mar 2019
22 enrolled
FLT3-mutated Acute Myeloid Leukemia
iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)
Started Nov 2018
0Acute Myeloid Leukemia